CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 3,650 shares at $15.02 ($54,829)
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $16.26 ($812,859)
- 4 Open-market sale Chief Executive Officer sold 616 shares at $16.92 ($10,426)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Executive Officer sold 49,384 shares at an average $16.30 ($805,183)
- 4 Open-market sale Chief Legal Officer sold 1,852 shares at $16.61 ($30,753)
- 4 Open-market sale Chief Business Officer sold 5,481 shares at an average $16.76 ($91,839)
- 4 Open-market sale Chief Legal Officer sold 21,639 shares at an average $16.78 ($363,077)
- 4 Open-market sale Chief Legal Officer sold 11,332 shares at an average $16.78 ($190,109)
- 4 Open-market sale Chief Business Officer sold 11,615 shares at an average $16.78 ($194,942)
- 4 Open-market sale Chief Executive Officer sold 50,000 shares at an average $17.88 ($893,918)
Page 23 of 26 · 502 filings